Mahnaz Pezeshpour
MD | Psychiatry | Child & Adolescent
501 Student Health, Irvine
California, 92697-5200
949-824-7747 949-824-0323
Maps & DirectionsMahnaz Pezeshpour is a Irvine, California based psychiatrist who is specialized in Child & Adolescent. Her current practice location is 501 Student Health, Irvine. Patients can reach her at 949-824-7747 or can fax her at 949-824-0323. Mahnaz Pezeshpour is MD in Child & Adolescent and her NPI number (Unique professional ID assigned by NPPES) is 1952513871.
Mahnaz Pezeshpour has done additional skills and training in the diagnosis and treatment of developmental, behavioral, emotional, and mental disorders of childhood and adolescence.
Complete Profile:
Mahnaz Pezeshpour speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
| Name: | Mahnaz Pezeshpour |
| Specialization: | Child & Adolescent |
| Gender: | Female |
| Credentials: | MD |
| Practice Address: | 501 Student Health, Irvine,
California, 92697-5200 |
| Phone: | 949-824-7747 |
| Fax: | 949-824-0323 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
| NPI Number: | 1952513871 |
| NPI Enumeration Date: | 04 May, 2007 |
| NPI Last Update On: | 06 Dec, 2021 |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | Mahnaz Pezeshpour
501 Student Health,
Irvine, California |
| Zip: | 92697-5200 |
| Phone Number: | 949-824-7747 |
| Fax Number: | 949-824-0323 |
Patients can reach Mahnaz Pezeshpour at
501 Student Health, Irvine, California or can
call to book an appointment on 949-824-7747.
*
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.